Brazilian Ministry of Health is the famous Corporate Investor, which was founded in 2008. The leading representative office of defined Corporate Investor is situated in the Rio Grande do Norte. The venture was found in South America in Brazil.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by National Multiple Sclerosis Society (NMSS), Israel Innovation Authority, California Institute for Regenerative Medicine.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline BrainStorm Cell Therapeutics Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Health Care.
The high activity for fund was in 2014. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars. The higher amount of exits for fund were in 2003.
Fund Name | Location |
Ascent Hydrogen Fund | - |
Barclays Bank | England, London, United Kingdom |
Barinboim Investment | - |
Beijing Chuangqi Yifeng Investment | Beijing, Beijing, China |
Biofund | Italy, Siena, Toscana |
EchoStar | Colorado, Englewood, United States |
H20 Capital | - |
Honeycomb Investment Trust | England, London, United Kingdom |
January Capital | Central Region, Singapore, Singapore |
Kunshan Kersen Science & Technology | China, Jiangsu, Suzhou |
MTGx | Stockholm, Stockholm County, Sweden |
Nanchang Xinshiji Chuangtou | China, Guangdong, Jiangxi |
OneSpan | Chicago, Illinois, United States |
OTP Bank | Budapest, Hungary |
Qiming Venture Partners USA | Cambridge, Massachusetts, United States |
Tribal.vc | County Dublin, Dublin, Ireland |
Upstart Life Ventures | Salt Lake City, United States, Utah |
Venus MedTech | China, Hangzhou, Zhejiang |
Xenon Ventures | Beaverton, Oregon, United States |
YungPark Capital | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.